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The gamma-herpesvirus Kaposi’s Sarcoma-associated
Herpesvirus (KSHV) is the etiological agent of Kaposi’s
Sarcoma (KS), Primary Effusion Lymphoma (PEL) and a
subset of Multicentric Castleman’s Disease (MCD) in
immunocompromised individuals. As all herpesviruses
KSHV has a latent and a lytic life cycle. Malignant cells in
KS, PEL, and MCD are latently infected with KSHV. Inter-
estingly, the virus encodes 12 miRNA genes giving rise to
25 mature miRNAs that are predominantly expressed dur-
ing latency, i.e. in malignant cells. This, together with the
increasing evidence for the involvement of miRNAs in
cancer, suggests a potential role for the KSHV miRNAs in
viral tumorigenesis. However, to date, very little is known
about the function of these viral miRNAs. To address the
question we performed Ago-HITS-CLIP [1] using the
anti-Ago antibody 2A8 [2] to isolate RISC complexes from
KSHV-infected lymphoma cells (BCBL1, BC3). RNAs
extracted from these complexes were analyzed by Illumina
sequencing to identify viral and cellular miRNAs and their
target genes. The search for canonical seed sequence
matches (nt 2-7) of the KSHV miRNAs within the
mRNA-derived sequencing tags revealed more than 1000
cellular targets. Gene ontology analysis revealed that
KSHV miRNA targets are enriched in genes involved in
apoptosis, lymphocyte activation, cell cycle regulation, and
transcriptional control. Importantly, we reproducibly
obtained clusters of reads on experimentally confirmed
KSHV miRNA target sites in several known target genes
(e.g. Bach1, BCLAF1, and THBS1). New target genes are
in the process of experimental validation, with 4 con-
firmed targets so far: TP53INP1, TPD52, ANXA2,
C/EBPB. Target analysis for non-canonical seeds as well as
for cellular miRNAs is currently ongoing.
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